Using Intravenous Immunoglobulins in Autoimmune Bullous Diseases-Reference-Cited by-同舟云学术

Using Intravenous Immunoglobulins in Autoimmune Bullous Diseases

Published:2015 Issue: Volume: Page:515-521
ISSN:
Container-title:Blistering Diseases
language:
Short-container-title:

Author:

Chee Shien-Ning,Murrell Dédée F.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-45698-9_52

Reference39 articles.

1. Gelfand E. Differences between IGIV products: impact on clinical outcome. Int Immunopharmacol. 2006;6:592–9.

2. National Blood Authority. National report on the issue and use of intravenous immunoglobulin (IVIg) for 2010–2011. Canberra: Commonwealth of Australia; 2012.

3. National Blood Authority. National blood agreement between the commonwealth of Australia and the State and territories. 2003. http://www.blood.gov.au/system/files/documents/nba-national-blood-agreement.pdf . Accessed 03 Mar 2012.

4. National Blood Authority. Criteria for the clinical use of intravenous immunoglobulin in Australia. 2012. http://www.blood.gov.au/system/files/documents/nba-ivig-criteria-for-use-2nd-edition.pdf . Accessed 20 December 2014.

5. Frauger E, Grassi J, Pradel V, et al. Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals. Fund Clin Pharmacol. 2011;25:753–61.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG;Dermatologic Therapy;2018-09

2. Successful treatment of a severe early onset case of pemphigoid gestationis with intravenous immunoglobulin in a twin pregnancy conceived with in vitro fertilisation in a primigravida;Journal of Obstetrics and Gynaecology;2016-12-06